In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

College Hill expands life sciences communications team

This article was originally published in Scrip

College Hill has appointed four new members to its life sciences team – Gurminder Marwaha, Cosima Zerdik, Dr Jo Bowler and Paul Jackson. Mr Marwaha has joined as senior account manager, having formerly worked as part of the life science PR team at Gyro International. As junior account manager, Ms Zerdik joins from the healthcare communications agency hsdcommunications (now part of Gyro International); previously she worked at Pfizer and Johnson & Johnson Medical. Dr Bowler joins as account executive and technical writer, bringing experience in life science research and communications having previously worked as learning and programmes communicator in the At-Bristol science centre. Paul Jackson joins as a web developer; he has four years' development experience working on digital projects.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC007200

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel